Several studies have reported that inflammatory markers are associated with atrial fibrillation (AF). White blood cell (WBC) count is a widely available and broadly utilized marker of systemic inflammation. We sought to investigate the association between increased WBC count and incident AF, and whether this association is mediated by smoking, myocardial infarction and heart failure. We examined participants in the Framingham Heart Study Original Cohort. Cox proportional hazard regression analysis was used to examine the relation between WBC count and incident AF over 5-year follow-up period. We adjusted for standard AF risk factors, and smoking, previous myocardial infarction, as well as interim myocardial infarction and heart failure prior to incident AF. Our sample consisted of 936 participants, mean age was 76±6 years and 61% were women. Median WBC count was 6.4*109/L (25th-75th percentile 5.6*109/L- 7.8*109/L). During a median follow-up of 5 years, 82 participants (9%) developed new-onset AF. After adjusting for standard risk factors for AF, increased WBC count was significantly associated with incident AF, with a hazard ratio per standard deviation (0.26*109/L) increase of 2.22, (95% confidence interval, 1.10–4.48; P=0.03). We found no substantive differences adjusting for smoking, previous myocardial infarction, interim myocardial infarction and heart failure. In conclusion, in our community-based sample, increased WBC count was associated with incident AF during 5-years of follow-up. Our findings provide additional evidence for the relation between systemic inflammation and AF.